Inventor · disambiguated record
Charles Olson
Also filed as: OLSON CHARLES · OLSON CHARLES V
10 granted patents·10 pending applications·163 citations·filing 1993–2024
89Inventor score
Files withAPPLIED MOLECULAR TRANSPORT INC8NGM BIOPHARMACEUTICALS INC3BAYER AG2GENENTECH INC2THORNHILL THERAPEUTICS INC2
Top patents by PatentIndex Score
20 records- 0196US11027020B2Delivery constructs for transcytosis and related methodsAPPLIED MOLECULAR TRANSPORT INC·Filed 2020·Granted Jun 8, 2021·7 cites·15 claims
- 0292US11214606B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Jan 4, 2022·3 cites·18 claims
- 0391US11324833B2Cholix-derived carriers for oral delivery of heterologous payloadAPPLIED MOLECULAR TRANSPORT INC·Filed 2020·Granted May 10, 2022·2 cites·16 claims
- 0491US10517929B2Pharmaceutical compositions comprising FGF19 variantsNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Dec 31, 2019·9 cites·82 claims
- 0582US5451660AMethod for purifying polypeptidesGENENTECH INC·Filed 1993·Granted Sep 19, 1995·55 cites·25 claims
- 0682US2025108118A1Cholix-derived carriers for oral delivery of heterologous payloadTHORNHILL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0779US6338964B1Process and medium for mammalian cell culture under low dissolved carbon dioxide concentrationBAYER AG·Filed 1999·Granted Jan 15, 2002·63 cites·14 claims
- 0878US11466067B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Oct 11, 2022·0 cites·17 claims
- 0978US2024238429A1Delivery constructs for transcytosis and related methodsTHORNHILL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1077US2024009316A1Cholix-derived carriers for oral delivery of heterologous payloadAPPLIED MOLECULAR TRANSPORT INC·Filed 2022·Application pending·0 cites
- 1172US11504433B2Cholix-derived carriers for oral delivery of heterologous payloadAPPLIED MOLECULAR TRANSPORT INC·Filed 2020·Granted Nov 22, 2022·0 cites·20 claims
- 1269US2022047675A1Pharmaceutical compositions comprising peptide variants and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1368US2021338828A1Delivery constructs for transcytosis and related methodsAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Application pending·0 cites
- 1467US5446024APurification of insulin-like growth factorGENENTECH INC·Filed 1993·Granted Aug 29, 1995·24 cites·19 claims
- 1567US2020197490A1Pharmaceutical compositions comprising peptide variants and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1650US2020207823A1Process for producing, isolating, and purifying modified recombinant proteinsCOHERUS BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1748US2005003507A1Method for purifying virusONYX PHARMA INC·Filed 2004·Application pending·0 cites
- 1847US2020140511A1Delivery constructs for transcytosis and related methodsAPPLIED MOLECULAR TRANSPORT INC·Filed 2019·Application pending·0 cites
- 1926US2017369551A1METHODS OF TREATING IgA NEPHROPATHY AND HENOCH-SCHONLEIN PURPURA NEPHRITIS USING A B-CELL ACTIVATING FACTOR (BAFF) INHIBITORANTHERA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2022US6214975B1Method for evaluating target protein quality from fermenterBAYER AG·Filed 1999·Granted Apr 10, 2001·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Charles Olson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →